Arkolith/Insider Trading/RCKT/Form 4

RTW Investments, LP

Director, 10% OwnerROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Sep 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2025Other(J)59K$3.11$183K18.2M
Sep 19, 2025Option exercise(X)1.0M$40.03$40.0M19.2M
Sep 19, 2025Other(J)1.0M$3.11$3.1M18.2M
Sep 19, 2025Option exercise(X)41K$19.09$783K18.2M
Sep 19, 2025Other(J)41K$3.11$128K18.2M
Sep 19, 2025Option exercise(X)59K$17.81$1.1M18.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2025Option exercise(X)1——0
Sep 19, 2025Option exercise(X)1——0
Sep 19, 2025Option exercise(X)1——0

Transaction Codes

J
Other acquisition / disposition
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000232) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML